Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 18;12(9):1715-1724.
doi: 10.21037/tp-23-60. Epub 2023 Sep 6.

Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

Affiliations

Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas

Piedad Alba-Pavón et al. Transl Pediatr. .

Abstract

Desmoid tumor (DT) is a fibroblastic proliferation arising in soft tissue characterized by localized infiltrative growth with an inability to metastasize but with a tendency to recurrence. Nuchal-type fibromas are benign soft tissue lesions that are usually developed in the posterior neck. The development of these neoplasms can be associated with a hereditary cancer predisposition syndrome, mainly familial adenomatous polyposis (FAP) syndrome caused by APC germline mutations. Gardner syndrome is a variant of FAP characterized by the presence of extracolonic manifestations including soft tissue tumors as DTs and nuchal-type fibromas. However, the development of these tumors could be associated with germline alterations in other genes related to colorectal cancer development. The objective of this study was to analyze germline variants in APC, MUTYH, POLD1 and POLE genes in five pediatric patients diagnosed with DTs or nuchal-type fibromas. We identified two pathogenic variants in the APC gene in two different patients diagnosed with nuchal-type fibroma and DTs and two variants of uncertain significance in POLD1 in two patients diagnosed with nuchal-type fibroma. Two patients had family history of colorectal cancer, however, only one of them showed an APC germline pathogenic variant. The analysis of germline variants and genetic counseling is essential for pediatric patients diagnosed with DTs or nuchal-type fibromas and their relatives.

Keywords: Desmoid tumor (DT); germline; next generation sequencing (NGS); nuchal-type fibroma.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-60/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Pedigrees of patients with colorectal polyposis or colon cancer family history. (A) Patient 2 diagnosed with desmoid tumor. (B) Patient 5 diagnosed with desmoid tumor with an APC germline pathogenic variant. Proband is indicated by arrow.
Figure 2
Figure 2
Germline variants identified in the analyzed patients. (A) APC germline pathogenic variants. (B) POLD1 germline variants of uncertain significance. AA, amino acids; EB1, End-binding protein 1; DLG, Discs large protein.

References

    1. Sakorafas GH, Nissotakis C, Peros G. Abdominal desmoid tumors. Surg Oncol 2007;16:131-42. 10.1016/j.suronc.2007.07.009 - DOI - PubMed
    1. Eastley N, McCulloch T, Esler C, et al. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions. Eur J Surg Oncol 2016;42:1071-83. 10.1016/j.ejso.2016.02.012 - DOI - PubMed
    1. Peña S, Brickman T, StHilaire H, et al. Aggressive fibromatosis of the head and neck in the pediatric population. Int J Pediatr Otorhinolaryngol 2014;78:1-4. 10.1016/j.ijporl.2013.10.058 - DOI - PubMed
    1. Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 2011;16:682-93. 10.1634/theoncologist.2010-0281 - DOI - PMC - PubMed
    1. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 2020;127:96-107. 10.1016/j.ejca.2019.11.013 - DOI - PubMed